The Miller School of Medicine joins forces with biopharmaceutical company Berg Pharma.
Miami University’s Miller School of Medicine and Boston-based biopharmaceutical firm Berg Pharma are to collaborate on drug research and development. The university is hoping this relationship will accelerate Miami’s push to become a hub in the biotech industry.
The collaboration is not entirely surprising, as Berg was co-founded by Miami University alumnus Niven R. Narain, who serves as president and chief technology officer. The company’s other co-founder, real estate billionaire Carl Berg, has allowed the six-year-old firm to grow to…
